Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TXGTXG
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in 10x Genomics Inc Class A

GOLDMAN SACHS GROUP INC holds 3.1M shares of TXG (10x Genomics Inc Class A), worth $120.7M as of 2026-Q2. The position was decreased (-20.7% shares). TXG represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$120.7M

Current Shares

3.1M

Total Value Change

+$117.2M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.1M
-20.7%
$120.7M0.0%$38.34
0
2026-Q1
Increased
4M
+28.6%
$84.3M0.0%$22.62
37
2025-Q4
Increased
3.1M
+15.4%
$50.4M0.0%$16.29
34
2025-Q3
Increased
2.7M
+340.2%
$31.3M0.0%$11.34
47
2025-Q2
Decreased
607,765
-5.8%
$7M0.0%$11.73
0
2025-Q1
Increased
645,366
+163.5%
$5.6M0.0%$9.16
44
2024-Q4
New
244,936
-
$3.5M0.0%$14.35
37

Other major holders of TXG: BAILLIE GIFFORD & CO, ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used